21st.BIO launches precision fermentation program for bovine alpha-lactalbumin
21st.BIO has announced the launch of the new development program for bovine alpha-lactalbumin (α-lac) after exclusively licensing the high-yield microbial strain from biosolutions company, Novonesis. This will allow 21st.BIO to deliver the protein—and the technology to produce it—to companies globally.
2025-07-10 21st.BIO